Skip to content

Office of Professional Education

View Live Events

48th Annual Pulmonary & Allergy Update

We are excited to offer several Product Theaters during the 48th Annual Pulmonary and Allergy Update. Product Theaters present new research findings on pharmaceutical products or disease states, provide product details, and highlight new drug and device approvals.

Please view the Product Theater schedule and additional information below. If you have any questions, please email ProEd@njhealth.org.

All Product Theaters will be held inside the Keystone Conference Center - Castle Peak (2nd Floor).



Type 2 Inflammation and the Lungs: Implications for Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Wednesday, January 28

7:15—8:15 p.m.

Dinner will be provided

Vamsi Pallavi Guntur, M.D., M.Sc.

Presenter: Vamsi Pallavi Guntur, M.D., M.Sc.

Sponsored by Sanofi Regeneron



Starting at the Top - A Different Approach to Severe Asthma and CRSwNP

Thursday, January 29

10:15—11:15 a.m.


Presenter: Luke Webb, MD

Sponsored by Amgen AstraZeneca



Exploring the Science Behind LAMA as an Add-on Therapy in Asthma  

Thursday, January 29

3:30—4:30 p.m.

Michael Wechsler, MD

Presenter: Michael E. Wechsler, MD

Join Michael Wechsler, MD, for a closer look at the scientific foundations of adding long-acting muscarinic antagonist (LAMA) therapy in asthma, examining cholinergic signaling and mechanistic insights into airway pathophysiology.


Sponsored by AstraZeneca



Two Diseases, One Dupixent: Inhibition of Two of the Key Drivers of Type 2 Inflammation in Asthma and COPD

Friday, January 30

10:15—11:15 a.m.

Lunch will be provided


Presenter: Steve White, MD


Sponsored by Sanofi Regeneron


 

Exdensur: New and Emerging Treatment in Severe Eosinophilic Asthma

Friday, January 30

3:30—4:30 p.m.


Presenter: Anil Nanda, MD, FAAAAI, FACAAI, FACP

Learn about suppression of type 2 inflammation, reduction in exacerbations and confidence in dosing with Exdensur, a new ultra long-lasting treatment for severe eosinophilic asthma


Sponsored by GSK



JASCAYD ® (nerandomilast) tablets: An Update to the Treatment Landscape

Friday, January 30

6:45—7:45 p.m.

Dinner will be provided


Presenter: Mary Beth Scholand, MD


Sponsored by Boehringer Ingelheim




Not part of the official programming of the 48th Annual National Jewish Health Pulmonary and Allergy Update. 

The promotional activities are provided by the identified sponsor and are not certified for continuing education credit. The content of the Product Theaters and opinions expressed by presenters are those of the sponsor or presenters and not of National Jewish Health.